WELL Interest Expense from 2010 to 2026
| WELL Stock | CAD 4.42 0.07 1.61% |
Interest Expense | First Reported 2011-03-31 | Previous Quarter 12.7 M | Current Value 18 M | Quarterly Volatility 4.3 M |
Financial statement trends for WELL Health provide structured context on operating performance and capital structure. The series highlights drivers like Interest Expense of 44.5 M, Selling General Administrative of 286 M or Other Operating Expenses of 1.1 B and ratios such as Price To Sales Ratio of 2.01, Dividend Yield of 0.0 or PTB Ratio of 1.26, complementing WELL Health Valuation and Volatility.
WELL | Interest Expense |
Evaluating WELL Health's Interest Expense across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into WELL Health Technologies's fundamental strength.
Latest WELL Health's Interest Expense Growth Pattern
Below is the plot of the Interest Expense of WELL Health Technologies over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. WELL Health's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in WELL Health's overall financial position and show how it may be relating to other accounts over time.
| Interest Expense | 10 Years Trend |
|
Interest Expense |
| Timeline |
WELL Interest Expense Regression Statistics
| Arithmetic Mean | 11,185,000 | |
| Geometric Mean | 139,442 | |
| Coefficient Of Variation | 152.41 | |
| Mean Deviation | 14,480,701 | |
| Median | 24,771 | |
| Standard Deviation | 17,046,917 | |
| Sample Variance | 290.6T | |
| Range | 44.5M | |
| R-Value | 0.84 | |
| Mean Square Error | 91.6T | |
| R-Squared | 0.70 | |
| Significance | 0.000025 | |
| Slope | 2,833,220 | |
| Total Sum of Squares | 4649.6T |
WELL Interest Expense History
WELL Health Valuation Metrics
WELL Health is a mid-cap equity in Health Care Providers & Services, Health Care Equipment & Services, Health Care categories. Profitability trends drive pricing sustainability. This analysis reviews how WELL Health integrates into a multi-asset portfolio across market cycles.
Methodology
Unless otherwise specified, financial data for WELL Health Technologies is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. WELL (CA:WELL) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
WELL Health Technologies may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Pair Trading with WELL Health
Pair trading with WELL Health can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Moving against WELL Stock
Sophisticated investors use correlation analysis to build WELL Health replacement strategies that go beyond simple sector matching. Assets with similar factor exposures to WELL Health Technologies provide the most accurate portfolio substitution during tax-loss harvesting periods.
Statistical correlation between WELL Health and its peers is an essential input for mean-variance portfolio optimization. Lower correlation of WELL Health Technologies with other holdings allows for a more efficient frontier with superior risk-adjusted returns.
Correlation analysis and pair evaluation for WELL Health can support hedging context. This approach is commonly reviewed within sectors and across broader groups.More Resources for WELL Stock Analysis
Other Information on Investing in WELL Stock
Financial ratios for WELL Health provide valuation context across profits, cash flow, and enterprise value. They help compare WELL across valuation measures in a consistent way.